Cargando…

Treatment of Hepatitis C in a Case of Pediatric B-Cell Acute Leukemia

The prevalence of hepatitis C virus (HCV) infection in Pediatric patients with lymphoproliferative diseases has most commonly been reported with B cell Non-Hodgkin lymphoma. Case studies have reported the requirement of dose reduction or suspension of chemotherapy in 80% of Pediatric ALL cases who a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jakhar, Nikita, Gera, Akriti, Mittal, Richa, Mehndiratta, Sumit, Shalimar, Singh, Amitabh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996459/ https://www.ncbi.nlm.nih.gov/pubmed/35418736 http://dx.doi.org/10.4103/jgid.jgid_1_21

Ejemplares similares

Comparison of clinical outcome between immunocompetent and immunocompromised children aged 1-12 years admitted with acute COVID 19 infection a retrospective review
por: Goel, Neha, et al.
Publicado: (2022)

Retrospective review of severe acute respiratory syndrome coronavirus-2 infection in children with acute leukemia from a tertiary care hospital in Northern India
por: Chhabra, Suhail, et al.
Publicado: (2021)

Pediatric dosing errors due to variable drug formulations
por: Mehndiratta, Sumit
Publicado: (2014)

Chronic hepatitis E – an emerging disease in an immunocompromised host
por: Singh, Amitabh, et al.
Publicado: (2018)

Current treatment for pediatric acute myeloid leukemia
por: Im, Ho Joon
Publicado: (2018)

Prognostic Scores in Acute Liver Failure Due to Viral Hepatitis
por: Biswas, Sagnik, et al.
Publicado: (2023)

Phenytoin-induced encephalopathy in a child
por: Mehndiratta, Sumit
Publicado: (2016)

Pathogenesis of pediatric B-cell acute lymphoblastic leukemia: Molecular pathways and disease treatments
por: Huang, Fang-Liang, et al.
Publicado: (2020)

Case Report: Blinatumomab as upfront consolidation and maintenance therapy in a pediatric patient with high-risk B-cell acute lymphoblastic leukemia
por: Gupta, Sumit, et al.
Publicado: (2023)

Resistance Mechanisms in Pediatric B-Cell Acute Lymphoblastic Leukemia
por: Jędraszek, Krzysztof, et al.
Publicado: (2022)

1709. Shifting Infection Spectrum in Febrile Neutropenic Pediatric Cancer Patients During the COVID-19 Pandemic: An Impact Assessment
por: Dabas, Aditya, et al.
Publicado: (2023)

Prognostic factors and treatment of pediatric acute lymphoblastic leukemia
por: Lee, Jae Wook, et al.
Publicado: (2017)

Antibody–Drug Conjugates for the Treatment of Acute Pediatric Leukemia
por: Stokke, Jamie L., et al.
Publicado: (2021)

Advances in the Diagnosis and Treatment of Pediatric Acute Lymphoblastic Leukemia
por: Inaba, Hiroto, et al.
Publicado: (2021)

Expression, Purification and Characterization of the Hepatitis E Virus Like-Particles in the Pichia pastoris
por: Gupta, Jyoti, et al.
Publicado: (2020)

Eight versus twelve weeks of sofosbuvir-velpatasvir in treatment-naïve non-cirrhotic patients with chronic hepatitis C virus infection: Study protocol for a multicentric, open labelled, randomized, non-inferiority trial (RESOLVE trial)
por: Awasthi, Ashish, et al.
Publicado: (2023)

Endoplasmic Reticulum Stress Induced Synthesis of a Novel Viral Factor Mediates Efficient Replication of Genotype-1 Hepatitis E Virus
por: Nair, Vidya P., et al.
Publicado: (2016)

Pediatric acute lymphoblastic leukemia
por: Inaba, Hiroto, et al.
Publicado: (2020)

Novel Markers in Pediatric Acute Lymphoid Leukemia: The Role of ADAM6 in B Cell Leukemia
por: Alsuwaidi, Laila, et al.
Publicado: (2021)

Genomic Profiling of Adult and Pediatric B-cell Acute Lymphoblastic Leukemia
por: Liu, Yuan-Fang, et al.
Publicado: (2016)

Oral Mucositis in Pediatric Patients in Treatment for Acute Lymphoblastic Leukemia
por: Ribeiro, Isabella Lima Arrais, et al.
Publicado: (2017)

Outcomes of pediatric acute myeloid leukemia treatment in Western Kenya
por: van Weelderen, Romy E., et al.
Publicado: (2021)

Upregulation of CD146 in Pediatric B-Cell Acute Lymphocytic Leukemia and Its Implications on Treatment Outcomes
por: Zahran, Asmaa M., et al.
Publicado: (2020)

Unrelated donor α/β T cell– and B cell–depleted HSCT for the treatment of pediatric acute leukemia
por: Leahy, Allison Barz, et al.
Publicado: (2022)

Cardiorenal syndrome followed by acute hepatitis C in a patient with acute myeloid leukemia
por: Mihaila, Romeo-Gabriel
Publicado: (2014)

Advances in Pediatric Acute Promyelocytic Leukemia
por: Conneely, Shannon E., et al.
Publicado: (2020)

Acute Leukemia Presenting in the Pediatric Orbit
por: Gounder, Pav, et al.
Publicado: (2022)

Personalized therapy in pediatric high-risk B-cell acute lymphoblastic leukemia
por: Karol, Seth E., et al.
Publicado: (2020)

Aberrant GATA2 Activation in Pediatric B-Cell Acute Lymphoblastic Leukemia
por: Wang, Han, et al.
Publicado: (2022)

P368: GENOMIC LANDSCAPE OF PEDIATRIC ACUTE B LYMPHOBLASTIC LEUKEMIA IN CHINA
por: Gao, Yangyang, et al.
Publicado: (2023)

Chromatin accessibility landscape of relapsed pediatric B-lineage acute lymphoblastic leukemia
por: Wang, Han, et al.
Publicado: (2023)

Prognostic impact of pretreatment immunoglobulin clonal composition in pediatric B-lymphoblastic leukemia
por: Fries, Carol, et al.
Publicado: (2022)

Maternal Chromium Levels in Gestational Diabetes: Systematic Review and Meta-Analysis
por: Sharma, Akriti K., et al.
Publicado: (2022)

Incidental detection of hepatitis B and C viruses and their coinfection in a hospital-based general population in tertiary care hospital of Uttar Pradesh
por: Agarwal, Loveleena, et al.
Publicado: (2018)

Host-Virus Protein Interaction Network Reveals the Involvement of Multiple Host Processes in the Life Cycle of Hepatitis E Virus
por: Subramani, Chandru, et al.
Publicado: (2018)

FPGS rs1544105 polymorphism is associated with treatment outcome in pediatric B-cell precursor acute lymphoblastic leukemia
por: Liu, Shu-Guang, et al.
Publicado: (2013)

CD19-negative relapse of pediatric B-cell precursor acute lymphoblastic leukemia following blinatumomab treatment
por: Mejstríková, E., et al.
Publicado: (2017)

Survival after blinatumomab treatment in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia
por: Gore, Lia, et al.
Publicado: (2018)

Upfront Treatment Influences the Composition of Genetic Alterations in Relapsed Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia
por: Yu, Jiangyan, et al.
Publicado: (2020)

Novel Treatments for Pediatric Relapsed or Refractory Acute B-Cell Lineage Lymphoblastic Leukemia: Precision Medicine Era
por: Mengxuan, Shang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_te3gdqt1noi468cu90qj0p900c